Storia in 2 fonti

Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x — Should you subscribe?

Symbiotec Pharmalab IPO enters its final bidding day with 5.31 times overall subscription and a Rs 285 GMP. The Rs 1,757 crore issue is priced at Rs 938–988 per share, with listing expected on September 1. Proceeds will partly repay debt, while investors weigh strong demand against premium valuation and risks.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo4 g fa

Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x — Should you subscribe?

originale

thehindubusinessline.com7 g fa

Symbiotec Pharmalab IPO sees subscription at 0.70x by mid-afternoon

The employee reservation portion led with 1.19 times subscription; Retail Individual Investors subscription at 0.82 times, NII category is at 0.86 times. QIB remained the weakest segment at 0.35 times

Timeline cronologica

lunedì 24 agosto 2026·economictimes.indiatimes.com
Tempsens Instruments IPO Day 3: GMP at 105%, subscription hits 21.66x. Should you subscribe?
Tempsens Instruments IPO saw strong investor demand, with the issue subscribed 21.66 times by Day 2, while the latest grey market premium (GMP) indicated a potential 105% listing…
lunedì 24 agosto 2026·thehindubusinessline.com
Symbiotec Pharmalab IPO sees subscription at 0.70x by mid-afternoon
The employee reservation portion led with 1.19 times subscription; Retail Individual Investors subscription at 0.82 times, NII category is at 0.86 times. QIB remained the weakest…

Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x — Should you subscribe?

Confronto fonti

Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x — Should you subscribe?

Symbiotec Pharmalab IPO sees subscription at 0.70x by mid-afternoon

Timeline cronologica

Tempsens Instruments IPO Day 3: GMP at 105%, subscription hits 21.66x. Should you subscribe?

Symbiotec Pharmalab IPO sees subscription at 0.70x by mid-afternoon

Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?

Hy-Tech Engineers IPO Day 3: GMP at 57%, subscription reaches 19.33x. Should you subscribe?

Skyways Air, Symbiotec Pharmalab IPOs Day 3: Cross 4x subscription

Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x — Should you subscribe?

Hy-Tech Engineers IPO Day 4: GMP signals 83% premium, subscription hits 50.86x. Apply?

Three IPOs close today: Skyways, Symbiotec, Hy Tech Engineers IPOs see strong subscription